MyFinsight
Home
About
Contact
tvtx: the income statement
Download
Download image
Tiopronin Products
$22,250K
FILSPARI
$90,900K
License
$51,709K
Product
$113,150K
Other income
(expense), net
$487K
(-6.35%↓ Y/Y)
Interest income
$3,047K
(-14.65%↓ Y/Y)
Total revenue
$164,859K
(162.11%↑ Y/Y)
Total other income,
net
$783K
(-40.37%↓ Y/Y)
Operating income (loss)
$24,931K
(144.40%↑ Y/Y)
Interest expense
$2,751K
(-0.94%↓ Y/Y)
Total operating
expenses
$139,928K
(17.54%↑ Y/Y)
Income (loss) from
continuing operations...
$25,714K
(146.89%↑ Y/Y)
Selling, general and
administrative
$86,453K
(31.75%↑ Y/Y)
Research and development
$51,890K
(0.41%↑ Y/Y)
Cost of goods sold
$1,585K
(-2.52%↓ Y/Y)
Income (loss) from
continuing operations, net...
$25,706K
(146.95%↑ Y/Y)
Income tax (provision)
benefit on continuing...
$8K
(109.52%↑ Y/Y)
Unrealized gain (loss) on
marketable debt securities
$42K
(-97.04%↓ Y/Y)
Net income (loss)
$25,706K
(146.90%↑ Y/Y)
Comprehensive income (loss)
$25,464K
(146.99%↑ Y/Y)
Foreign currency
translation (loss) gain
-$284K
(64.63%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)